Free Trial
→ Elon Musk’s Frightening Warning Forces Trump’s Hand (From American Hartford Gold) (Ad) Buy ALHC Stock  Free ALHC Stock Alerts

Alignment Healthcare (ALHC) Financials

Alignment Healthcare logo
$14.90 -0.15 (-1.00%)
Closing price 05/29/2025 04:00 PM Eastern
Extended Trading
$14.90 -0.01 (-0.03%)
As of 05/29/2025 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Alignment Healthcare

Annual Income Statements for Alignment Healthcare

This table shows Alignment Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Net Income / (Loss) Attributable to Common Shareholders		 -128 -148 -150 -195 -23 -45
Consolidated Net Income / (Loss)		 -128 -148 -150 -195 -23 -45
Net Income / (Loss) Continuing Operations		 -128 -148 -150 -195 -23 -45
Total Pre-Tax Income 		-128 -148 -149 -195 -23 -45
Total Operating Income		 -102 -128 -129 -178 -5.26 -29
Total Gross Profit		 2,704 1,824 1,434 1,168 959 757
Total Revenue		 2,704 1,824 1,434 1,168 959 757
Operating Revenue		 2,704 1,824 1,434 1,168 959 757
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 2,805 1,951 1,563 1,346 964 786
Selling, General & Admin Expense		 371 307 296 291 156 110
Depreciation Expense		 27 21 17 16 15 15
Other Operating Expenses / (Income)		 2,407 1,623 1,250 1,039 793 661
Total Other Income / (Expense), net		 -27 -21 -20 -17 -18 -15
Interest Expense		 27 21 20 17 17 15
Income Tax Expense		 0.02 -0.02 0.34 0.00 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.04 -0.16 -0.09 0.00 0.00 -
Basic Earnings per Share		 ($0.67) ($0.79) ($0.83) ($1.14) ($0.15) ($0.33)
Weighted Average Basic Shares Outstanding		 190.79M 186.21M 181.21M 171.96M 152.13M 135.86M
Diluted Earnings per Share		 ($0.67) ($0.79) ($0.83) ($1.14) ($0.15) ($0.33)
Weighted Average Diluted Shares Outstanding		 190.79M 186.21M 181.21M 171.96M 152.13M 135.86M
Weighted Average Basic & Diluted Shares Outstanding		 191.83M 188.98M 181.21M 171.96M 152.13M 135.86M

Quarterly Income Statements for Alignment Healthcare

This table shows Alignment Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 -9.11 -31 -26 -24 -47 -47 -35 -28 -37 -57 -40
Consolidated Net Income / (Loss)		 -9.35 -31 -26 -24 -47 -47 -35 -28 -37 -57 -40
Net Income / (Loss) Continuing Operations		 -9.35 -31 -26 -24 -47 -47 -35 -28 -37 -58 -40
Total Pre-Tax Income 		-9.33 -31 -26 -24 -47 -47 -35 -28 -37 -57 -40
Total Operating Income		 -5.39 -23 -20 -18 -41 -42 -30 -24 -32 -52 -33
Total Gross Profit		 927 701 692 681 629 465 457 462 439 362 360
Total Revenue		 927 701 692 681 629 465 457 462 439 362 360
Operating Revenue		 927 701 692 681 629 465 457 462 439 362 360
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 932 724 712 700 670 507 486 486 472 414 394
Selling, General & Admin Expense		 104 102 91 88 91 84 83 70 70 83 76
Depreciation Expense		 7.59 6.76 7.64 6.49 5.98 5.80 5.50 5.20 4.92 4.69 4.46
Other Operating Expenses / (Income)		 821 615 613 605 573 418 398 411 396 326 313
Total Other Income / (Expense), net		 -3.94 -8.56 -6.94 -5.60 -5.47 -6.05 -5.47 -4.83 -4.88 -5.43 -6.67
Interest Expense		 3.95 8.51 6.94 5.69 5.43 5.48 5.47 5.26 5.02 4.79 6.80
Other Income / (Expense), net		 0.01 - - 0.09 -0.04 - - 0.43 0.14 - 0.13
Income Tax Expense		 0.02 0.01 -0.01 0.02 0.00 -0.02 0.00 0.00 0.00 0.17 0.17
Net Income / (Loss) Attributable to Noncontrolling Interest		 -0.24 0.03 -0.02 0.01 -0.05 -0.02 -0.03 -0.02 -0.09 -0.09 0.00
Basic Earnings per Share		 ($0.05) ($0.15) ($0.14) ($0.13) ($0.25) ($0.25) ($0.19) ($0.15) ($0.20) ($0.32) ($0.22)
Weighted Average Basic Shares Outstanding		 193.61M 190.79M 191.36M 190.89M 189.01M 186.21M 187.33M 185.99M 183.11M 181.21M 182.12M
Diluted Earnings per Share		 ($0.05) ($0.15) ($0.14) ($0.13) ($0.25) ($0.25) ($0.19) ($0.15) ($0.20) ($0.32) ($0.22)
Weighted Average Diluted Shares Outstanding		 193.61M 190.79M 191.36M 190.89M 189.01M 186.21M 187.33M 185.99M 183.11M 181.21M 182.12M
Weighted Average Basic & Diluted Shares Outstanding		 197.84M 191.83M 191.70M 191.30M 191.20M 188.98M 0.00 185.99M 183.11M 181.21M 0.00

Annual Cash Flow Statements for Alignment Healthcare

This table details how cash moves in and out of Alignment Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Net Change in Cash & Equivalents		 230 -206 -57 261 121 52
Net Cash From Operating Activities		 35 -59 -45 -79 7.56 9.21
Net Cash From Continuing Operating Activities		 35 -59 -45 -79 7.56 9.21
Net Income / (Loss) Continuing Operations		 -128 -148 -150 -195 -23 -45
Consolidated Net Income / (Loss)		 -128 -148 -150 -195 -23 -45
Depreciation Expense		 27 22 17 16 15 17
Amortization Expense		 1.29 1.25 1.85 2.25 2.19 1.95
Non-Cash Adjustments To Reconcile Net Income		 74 64 72 114 9.58 6.41
Changes in Operating Assets and Liabilities, net		 61 2.03 13 -16 3.25 29
Net Cash From Investing Activities		 39 -147 -28 -21 -16 -10
Net Cash From Continuing Investing Activities		 39 -147 -28 -21 -16 -10
Purchase of Property, Plant & Equipment		 -41 -36 -28 -18 -16 -10
Purchase of Investments		 -82 -379 -2.83 -2.48 -1.58 -0.32
Sale of Property, Plant & Equipment		 0.01 0.00 0.00 - 0.10 0.00
Sale and/or Maturity of Investments		 163 268 2.43 1.43 0.83 0.33
Net Cash From Financing Activities		 156 0.11 17 360 130 53
Net Cash From Continuing Financing Activities		 156 0.11 17 360 130 53
Repayment of Debt		 -224 0.00 -148 0.00 0.00 -0.85
Payment of Dividends		 0.00 0.00 -0.10 0.00 0.00 0.00
Issuance of Debt		 380 0.00 165 0.00 0.00 55
Issuance of Common Equity		 0.02 0.11 0.07 391 135 0.50
Other Financing Activities, net		 -0.20 0.00 0.00 - - -
Cash Interest Paid		 22 19 22 11 11 9.53

Quarterly Cash Flow Statements for Alignment Healthcare

This table details how cash moves in and out of Alignment Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 13 92 1.63 100 36 -188 -3.62 11 -25 -158 114
Net Cash From Operating Activities		 17 -8.71 26 24 -6.24 -187 5.99 37 85 -149 105
Net Cash From Continuing Operating Activities		 17 -8.71 26 24 -6.24 -187 5.99 37 85 -149 105
Net Income / (Loss) Continuing Operations		 -9.35 -31 -26 -24 -47 -47 -35 -28 -37 -57 -40
Consolidated Net Income / (Loss)		 -9.35 -31 -26 -24 -47 -47 -35 -28 -37 -57 -40
Depreciation Expense		 7.63 6.81 7.69 6.54 6.03 5.86 5.56 5.26 4.98 4.75 4.51
Amortization Expense		 0.44 0.32 0.37 0.09 0.52 0.22 0.30 0.43 0.31 0.23 0.48
Non-Cash Adjustments To Reconcile Net Income		 17 19 17 17 20 17 12 12 22 19 8.30
Changes in Operating Assets and Liabilities, net		 0.69 -3.94 27 24 13 -164 23 47 95 -117 132
Net Cash From Investing Activities		 -3.46 -5.92 -25 27 43 -1.02 -9.61 -26 -110 -8.11 -8.13
Net Cash From Continuing Investing Activities		 -3.46 -5.92 -25 27 43 -1.02 -9.61 -26 -110 -8.11 -8.13
Purchase of Property, Plant & Equipment		 -8.25 -9.28 -9.28 -12 -11 -11 -9.55 -8.56 -7.29 -8.11 -7.83
Purchase of Investments		 -18 -6.68 -36 -18 -22 -97 -125 -53 -104 - -1.73
Sale and/or Maturity of Investments		 23 10 20 57 75 107 125 35 1.10 - 1.43
Net Cash From Financing Activities		 0.18 107 - 49 -0.34 0.05 - 0.03 0.03 -0.53 17
Net Cash From Continuing Financing Activities		 0.18 107 - 49 -0.34 0.05 - 0.03 0.03 -0.53 17
Repayment of Debt		 -0.03 -223 - - - - - - - -0.60 -
Issuance of Common Equity		 0.00 - - - 0.02 0.05 - 0.03 0.03 0.07 -
Other Financing Activities, net		 0.21 0.16 - - -0.35 - - - 0.00 - -
Cash Interest Paid		 0.00 6.56 5.36 5.07 5.18 5.22 4.96 4.71 4.28 - 17

Annual Balance Sheets for Alignment Healthcare

This table presents Alignment Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Total Assets		 782 592 634 631 339
Total Current Assets		 662 484 545 553 265
Cash & Equivalents		 433 203 410 467 207
Short-Term Investments		 38 116 0.00 - -
Accounts Receivable		 154 120 93 59 40
Prepaid Expenses		 37 45 42 28 17
Plant, Property, & Equipment, net		 67 52 37 30 27
Total Noncurrent Assets		 53 56 52 48 47
Goodwill		 35 35 35 35 35
Intangible Assets		 4.55 5.25 5.48 - -
Other Noncurrent Operating Assets		 14 16 12 13 12
Total Liabilities & Shareholders' Equity		 782 592 634 631 339
Total Liabilities		 681 434 395 325 308
Total Current Liabilities		 352 263 230 167 153
Accounts Payable		 22 24 32 17 16
Current Employee Benefit Liabilities		 40 34 - - -
Other Current Liabilities		 290 205 170 126 113
Total Noncurrent Liabilities		 329 171 165 158 154
Long-Term Debt		 321 162 161 151 144
Other Noncurrent Operating Liabilities		 7.84 8.97 3.70 6.98 10
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 101 158 239 306 31
Total Preferred & Common Equity		 100 157 238 306 31
Preferred Stock		 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 100 157 238 306 31
Common Stock		 1,108 1,037 970 889 410
Retained Earnings		 -1,008 -880 -732 -583 -380
Noncontrolling Interest		 1.10 1.13 1.18 0.02 0.00

Quarterly Balance Sheets for Alignment Healthcare

This table presents Alignment Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets		 896 692 716 633 771 784 762 778
Total Current Assets		 774 574 599 521 667 684 671 692
Cash & Equivalents		 446 340 339 239 392 395 384 567
Short-Term Investments		 33 41 25 63 124 122 103 -
Accounts Receivable		 214 139 183 165 106 89 125 88
Prepaid Expenses		 81 54 52 54 46 77 58 36
Plant, Property, & Equipment, net		 69 65 62 57 47 43 40 36
Total Noncurrent Assets		 53 54 55 55 57 57 51 50
Goodwill		 34 35 35 35 40 40 40 38
Intangible Assets		 4.55 4.55 5.20 5.22 - - - -
Other Noncurrent Operating Assets		 14 15 15 15 17 17 11 12
Total Liabilities & Shareholders' Equity		 896 692 716 633 771 784 762 778
Total Liabilities		 787 577 591 501 581 572 538 505
Total Current Liabilities		 457 358 372 331 410 402 374 340
Accounts Payable		 28 25 23 23 25 21 23 21
Current Employee Benefit Liabilities		 32 - - - - - - -
Other Current Liabilities		 397 297 315 276 203 207 186 171
Total Noncurrent Liabilities		 330 219 220 170 171 171 164 165
Long-Term Debt		 322 210 212 162 162 161 161 161
Other Noncurrent Operating Liabilities		 7.65 8.19 8.18 8.44 9.32 9.21 2.50 4.46
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 109 116 125 132 190 211 224 272
Total Preferred & Common Equity		 108 115 124 131 189 210 223 272
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 108 115 124 131 189 210 223 272
Common Stock		 1,126 1,092 1,074 1,058 1,022 1,008 992 947
Retained Earnings		 -1,017 -977 -951 -927 -833 -798 -770 -675
Noncontrolling Interest		 0.86 1.08 1.09 1.09 1.10 1.13 1.12 0.00

Annual Metrics And Ratios for Alignment Healthcare

This table displays calculated financial ratios and metrics derived from Alignment Healthcare's official financial filings.

Metric 2024 2023 2022 2021 2020 2019
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Growth Metrics		 - - - - - -
Revenue Growth		 48.25% 27.16% 22.81% 21.74% 26.72% 0.00%
EBITDA Growth		 30.22% 4.03% 31.50% -1,468.64% 203.14% 0.00%
EBIT Growth		 20.55% 0.64% 27.67% -2,866.52% 79.91% 0.00%
NOPAT Growth		 20.55% 0.64% 27.76% -3,283.47% 82.15% 0.00%
Net Income Growth		 13.57% 0.98% 23.37% -751.81% 48.75% 0.00%
EPS Growth		 15.19% 4.82% 27.19% -660.00% 54.55% 0.00%
Operating Cash Flow Growth		 158.75% -30.29% 42.33% -1,141.87% -17.89% 0.00%
Free Cash Flow Firm Growth		 78.22% -10.21% 38.46% -610.46% 0.00% 0.00%
Invested Capital Growth		 -4,627.86% 111.41% 5.84% 69.49% 0.00% 0.00%
Revenue Q/Q Growth		 9.56% 6.02% 4.64% -13.97% 0.00% 0.00%
EBITDA Q/Q Growth		 25.71% 9.71% -9.07% -10.85% 0.00% 0.00%
EBIT Q/Q Growth		 16.02% 7.39% -7.84% -9.63% 0.00% 0.00%
NOPAT Q/Q Growth		 16.02% 7.39% -7.20% -9.65% 0.00% 0.00%
Net Income Q/Q Growth		 11.21% 6.18% -6.52% -8.78% 0.00% 0.00%
EPS Q/Q Growth		 12.99% 8.14% -7.79% -5.56% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 124.15% -182.06% -161.64% -34.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 88.88% -49.38% -474.76% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 9.53% 100.65% 93.06% 62.47% 0.00% 0.00%
Profitability Metrics		 - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -2.71% -5.75% -7.62% -13.66% 1.22% -1.49%
Operating Margin		 -3.76% -7.01% -8.97% -15.25% -0.55% -3.90%
EBIT Margin		 -3.76% -7.01% -8.97% -15.23% -0.63% -3.94%
Profit (Net Income) Margin		 -4.74% -8.13% -10.43% -16.72% -2.39% -5.91%
Tax Burden Percent		 100.02% 99.99% 100.23% 100.00% 100.00% 100.00%
Interest Burden Percent		 126.09% 115.94% 116.06% 109.81% 382.42% 149.93%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -98.89% -74.58% -54.88% -116.01% -74.89% 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% -9,369.88% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -14.78% -20.86% -20.34% -36.69% -1.77% 0.00%
Return on Assets (ROA)		 -18.64% -24.18% -23.66% -40.29% -6.77% 0.00%
Return on Common Equity (ROCE)		 -98.04% -74.14% -54.76% -116.01% -74.89% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 -128.26% -94.41% -62.84% -63.81% -74.89% 0.00%
Net Operating Profit after Tax (NOPAT)		 -71 -89 -90 -125 -3.68 -21
NOPAT Margin		 -2.63% -4.91% -6.28% -10.67% -0.38% -2.73%
Net Nonoperating Expense Percent (NNEP)		 -37.22% -28.94% -21.11% -37.26% -60.95% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 -16.83% -27.97% -22.50% - - -
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 13.74% 16.86% 20.61% 24.92% 16.30% 14.55%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 103.76% 107.01% 108.97% 115.25% 100.55% 103.90%
Earnings before Interest and Taxes (EBIT)		 -102 -128 -129 -178 -6.00 -30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -73 -105 -109 -160 12 -11
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 21.60 10.37 9.25 8.60 15.99 0.00
Price to Tangible Book Value (P/TBV)		 35.66 13.93 11.13 9.72 0.00 0.00
Price to Revenue (P/Rev)		 0.80 0.89 1.54 2.25 0.51 0.65
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1,381.12 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.74 0.81 1.36 1.98 0.44 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 36.58 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 57.76 0.00 0.00 0.00 56.40 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 14.78 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 3.18 1.02 0.67 0.49 4.71 0.00
Long-Term Debt to Equity		 3.18 1.02 0.67 0.49 4.71 0.00
Financial Leverage		 -1.18 -1.02 -1.04 -1.13 -2.06 0.00
Leverage Ratio		 5.30 3.08 2.32 2.88 11.06 0.00
Compound Leverage Factor		 6.69 3.58 2.69 3.16 42.29 0.00
Debt to Total Capital		 76.10% 50.58% 40.21% 32.98% 82.49% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 76.10% 50.58% 40.21% 32.98% 82.49% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.26% 0.35% 0.29% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 23.64% 49.06% 59.50% 67.01% 17.51% 0.00%
Debt to EBITDA		 -4.39 -1.54 -1.47 -0.94 12.37 0.00
Net Debt to EBITDA		 2.04 1.50 2.27 1.98 -5.42 0.00
Long-Term Debt to EBITDA		 -4.39 -1.54 -1.47 -0.94 12.37 0.00
Debt to NOPAT		 -4.52 -1.81 -1.79 -1.21 -39.13 0.00
Net Debt to NOPAT		 2.10 1.75 2.76 2.53 17.14 0.00
Long-Term Debt to NOPAT		 -4.52 -1.81 -1.79 -1.21 -39.13 0.00
Altman Z-Score		 3.60 2.99 3.92 5.22 2.55 0.00
Noncontrolling Interest Sharing Ratio		 0.86% 0.58% 0.22% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Current Ratio		 1.88 1.84 2.37 3.31 1.72 0.00
Quick Ratio		 1.78 1.67 2.18 3.14 1.61 0.00
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 -22 -100 -91 -147 29 0.00
Operating Cash Flow to CapEx		 83.98% -164.43% -163.31% -429.06% 48.44% 89.88%
Free Cash Flow to Firm to Interest Expense		 -0.82 -4.70 -4.42 -8.44 1.70 0.00
Operating Cash Flow to Interest Expense		 1.31 -2.79 -2.22 -4.52 0.45 0.62
Operating Cash Flow Less CapEx to Interest Expense		 -0.25 -4.48 -3.58 -5.57 -0.48 -0.07
Efficiency Ratios		 - - - - - -
Asset Turnover		 3.94 2.98 2.27 2.41 2.83 0.00
Accounts Receivable Turnover		 19.76 17.15 18.95 23.67 23.90 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 45.42 40.95 42.48 40.62 35.34 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 18.47 21.28 19.27 15.42 15.27 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 18.47 21.28 19.27 15.42 15.27 0.00
Capital & Investment Metrics		 - - - - - -
Invested Capital		 -48 1.07 -9.35 -9.93 -33 0.00
Invested Capital Turnover		 -114.56 -440.54 -148.85 -55.01 -58.97 0.00
Increase / (Decrease) in Invested Capital		 -49 10 0.58 23 -33 0.00
Enterprise Value (EV)		 2,008 1,472 1,955 2,317 426 0.00
Market Capitalization		 2,157 1,628 2,202 2,633 490 490
Book Value per Share		 $0.52 $0.83 $1.27 $1.63 $0.20 $0.00
Tangible Book Value per Share		 $0.32 $0.62 $1.06 $1.45 ($0.03) $0.00
Total Capital		 422 320 400 457 175 0.00
Total Debt		 321 162 161 151 144 0.00
Total Long-Term Debt		 321 162 161 151 144 0.00
Net Debt		 -149 -157 -249 -316 -63 0.00
Capital Expenditures (CapEx)		 41 36 28 18 16 10
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -161 -98 -95 -81 -96 0.00
Debt-free Net Working Capital (DFNWC)		 310 221 315 386 111 0.00
Net Working Capital (NWC)		 310 221 315 386 111 0.00
Net Nonoperating Expense (NNE)		 57 59 60 71 19 24
Net Nonoperating Obligations (NNO)		 -149 -157 -249 -316 -63 0.00
Total Depreciation and Amortization (D&A)		 28 23 19 18 18 19
Debt-free, Cash-free Net Working Capital to Revenue		 -5.95% -5.39% -6.62% -6.94% -10.02% 0.00%
Debt-free Net Working Capital to Revenue		 11.46% 12.09% 21.94% 33.02% 11.60% 0.00%
Net Working Capital to Revenue		 11.46% 12.09% 21.94% 33.02% 11.60% 0.00%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 ($0.67) ($0.79) ($0.83) ($1.14) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 190.79M 186.21M 187.28M 187.07M 0.00 0.00
Adjusted Diluted Earnings per Share		 ($0.67) ($0.79) ($0.83) ($1.14) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 190.79M 186.21M 187.28M 187.07M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($1.14) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 191.83M 188.98M 181.21M 171.96M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 -71 -89 -90 -125 -3.68 -21
Normalized NOPAT Margin		 -2.63% -4.91% -6.28% -10.67% -0.38% -2.73%
Pre Tax Income Margin		 -4.74% -8.13% -10.41% -16.72% -2.39% -5.91%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 -3.82 -6.02 -6.28 -10.20 -0.35 -2.00
NOPAT to Interest Expense		 -2.68 -4.21 -4.40 -7.15 -0.22 -1.39
EBIT Less CapEx to Interest Expense		 -5.38 -7.72 -7.64 -11.25 -1.28 -2.69
NOPAT Less CapEx to Interest Expense		 -4.23 -5.91 -5.75 -8.20 -1.14 -2.07
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% -0.07% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% -0.07% -15.61% -21.27% -4.43%

Quarterly Metrics And Ratios for Alignment Healthcare

This table displays calculated financial ratios and metrics derived from Alignment Healthcare's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 47.46% 50.68% 51.61% 47.34% 43.14% 28.63% 26.74% 26.17% 27.10% 21.30% 22.79%
EBITDA Growth		 107.76% 56.96% 51.99% 33.52% -27.84% 23.95% 15.55% -1,150.04% 15.05% -21.89% 22.91%
EBIT Growth		 86.92% 46.21% 34.39% 21.27% -27.19% 19.56% 10.59% -274.33% 11.16% -20.11% 19.62%
NOPAT Growth		 86.88% 46.21% 34.39% 22.30% -26.52% 19.56% 10.94% -255.88% 10.93% -19.88% 19.40%
Net Income Growth		 79.92% 34.23% 24.65% 15.76% -24.63% 17.13% 12.85% -146.06% 8.44% -19.15% 12.16%
EPS Growth		 80.00% 40.00% 26.32% 13.33% -25.00% 21.88% 13.64% -150.00% 13.04% -23.08% 15.38%
Operating Cash Flow Growth		 366.37% 95.35% 337.08% -36.71% -107.33% -25.59% -94.30% 259.06% 831.31% -395.33% 714.00%
Free Cash Flow Firm Growth		 130.09% 184.41% -1,498.62% -206.40% -261.51% -7.28% -89.49% 2,161.49% 245.10% 30.13% 3,396.85%
Invested Capital Growth		 -535.28% -4,627.86% 67.54% 81.27% 92.54% 111.41% -22.09% -2,490.05% -3,017.27% 5.84% -409.11%
Revenue Q/Q Growth		 32.18% 1.27% 1.64% 8.38% 35.07% 1.90% -1.23% 5.29% 21.38% 0.41% -1.67%
EBITDA Q/Q Growth		 117.40% -34.46% 1.62% 66.30% 14.80% -49.99% -36.23% 35.20% 43.53% -66.56% -1,916.39%
EBIT Q/Q Growth		 76.12% -15.49% -6.74% 55.55% 1.49% -40.86% -28.09% 28.19% 38.86% -56.57% -436.24%
NOPAT Q/Q Growth		 76.08% -15.49% -6.20% 55.28% 1.93% -40.86% -25.77% 27.18% 37.65% -55.96% -402.56%
Net Income Q/Q Growth		 69.89% -17.54% -10.11% 48.46% 1.39% -34.65% -23.10% 23.75% 34.43% -41.61% -247.56%
EPS Q/Q Growth		 66.67% -7.14% -7.69% 48.00% 0.00% -31.58% -26.67% 25.00% 37.50% -45.45% -266.67%
Operating Cash Flow Q/Q Growth		 290.75% -133.26% 11.31% 477.19% 96.67% -3,228.60% -83.88% -56.32% 157.02% -241.99% 915.26%
Free Cash Flow Firm Q/Q Growth		 11.04% 126.91% 4.61% -5.59% -211.43% -545.89% -92.74% 60.29% 306.85% -143.70% 1,522.83%
Invested Capital Q/Q Growth		 -0.88% 9.53% -96.37% -254.44% -819.04% 100.65% -13.34% -41.23% -998.80% 93.06% -2,304.45%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 0.29% -2.20% -1.66% -1.71% -5.50% -7.70% -5.23% -3.79% -6.16% -13.02% -7.85%
Operating Margin		 -0.58% -3.22% -2.82% -2.70% -6.54% -9.01% -6.52% -5.12% -7.40% -14.40% -9.27%
EBIT Margin		 -0.58% -3.22% -2.82% -2.68% -6.55% -9.01% -6.52% -5.02% -7.37% -14.40% -9.24%
Profit (Net Income) Margin		 -1.01% -4.43% -3.82% -3.52% -7.41% -10.15% -7.68% -6.16% -8.51% -15.75% -11.17%
Tax Burden Percent		 100.23% 100.02% 99.97% 100.09% 100.00% 99.95% 100.00% 100.00% 100.00% 100.30% 100.42%
Interest Burden Percent		 173.38% 137.76% 135.42% 131.12% 113.19% 112.75% 117.88% 122.65% 115.51% 109.05% 120.44%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -75.39% -98.89% -94.51% -91.03% -88.42% -74.58% -68.41% -64.62% -56.53% -54.88% -47.05%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -9,369.88% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -2.28% -12.65% -9.51% -7.99% -18.89% -26.80% -14.48% -11.25% -15.98% -32.66% -17.65%
Return on Assets (ROA)		 -3.96% -17.43% -12.88% -10.49% -21.38% -30.20% -17.06% -13.80% -18.46% -35.73% -21.34%
Return on Common Equity (ROCE)		 -74.78% -98.04% -93.84% -90.43% -87.88% -74.14% -68.24% -64.48% -56.41% -54.76% -47.05%
Return on Equity Simple (ROE_SIMPLE)		 -84.02% 0.00% -125.92% -123.59% -120.20% 0.00% -83.78% -77.68% -65.61% 0.00% -51.62%
Net Operating Profit after Tax (NOPAT)		 -3.78 -16 -14 -13 -29 -29 -21 -17 -23 -36 -23
NOPAT Margin		 -0.41% -2.25% -1.97% -1.89% -4.58% -6.30% -4.56% -3.58% -5.18% -10.08% -6.49%
Net Nonoperating Expense Percent (NNEP)		 -3.75% -9.98% -4.88% -4.38% -7.63% -8.82% -3.75% -3.64% -4.69% -7.27% -4.45%
Return On Investment Capital (ROIC_SIMPLE)		 -0.88% -3.74% - - - -9.17% - - - -9.11% -
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 11.20% 14.56% 13.12% 12.90% 14.40% 17.99% 18.19% 15.18% 16.03% 23.00% 21.22%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 100.58% 103.22% 102.82% 102.70% 106.54% 109.01% 106.52% 105.12% 107.40% 114.40% 109.27%
Earnings before Interest and Taxes (EBIT)		 -5.38 -23 -20 -18 -41 -42 -30 -23 -32 -52 -33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.68 -15 -11 -12 -35 -36 -24 -18 -27 -47 -28
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 33.03 21.60 19.74 12.09 7.16 10.37 6.94 5.16 5.35 9.25 8.15
Price to Tangible Book Value (P/TBV)		 51.48 35.66 30.08 17.87 10.32 13.93 8.81 6.38 6.52 11.13 9.45
Price to Revenue (P/Rev)		 1.19 0.80 0.92 0.67 0.47 0.89 0.76 0.67 0.78 1.54 1.62
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 1,381.12 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 1.14 0.74 0.85 0.60 0.40 0.81 0.56 0.45 0.57 1.36 1.32
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 59.27 57.76 0.00 0.00 0.00 0.00 0.00 9.32 16.87 0.00 24.56
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18.09 71.35 0.00 74.86
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 2.95 3.18 1.83 1.70 1.23 1.02 0.85 0.76 0.72 0.67 0.59
Long-Term Debt to Equity		 2.95 3.18 1.82 1.70 1.23 1.02 0.85 0.76 0.72 0.67 0.59
Financial Leverage		 -1.23 -1.18 -1.71 -1.51 -1.31 -1.02 -1.65 -1.30 -1.20 -1.04 -1.27
Leverage Ratio		 6.34 5.30 4.79 4.46 3.92 3.08 3.35 2.87 2.72 2.32 2.40
Compound Leverage Factor		 11.00 7.31 6.49 5.85 4.44 3.48 3.95 3.52 3.15 2.53 2.89
Debt to Total Capital		 74.70% 76.10% 64.71% 62.92% 55.10% 50.58% 46.01% 43.32% 41.84% 40.21% 37.12%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.49% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 74.70% 76.10% 64.22% 62.92% 55.10% 50.58% 46.01% 43.32% 41.84% 40.21% 37.12%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.20% 0.26% 0.33% 0.32% 0.37% 0.35% 0.31% 0.30% 0.29% 0.29% 0.00%
Common Equity to Total Capital		 25.10% 23.64% 34.96% 36.76% 44.53% 49.06% 53.67% 56.37% 57.87% 59.50% 62.88%
Debt to EBITDA		 -8.95 -4.39 -2.15 -1.91 -1.39 -1.54 -1.39 -1.34 -1.54 -1.47 -1.60
Net Debt to EBITDA		 4.38 2.04 1.72 1.37 1.20 1.50 3.05 2.95 3.12 2.27 4.06
Long-Term Debt to EBITDA		 -8.95 -4.39 -2.14 -1.91 -1.39 -1.54 -1.39 -1.34 -1.54 -1.47 -1.60
Debt to NOPAT		 -6.98 -4.52 -2.50 -2.31 -1.70 -1.81 -1.67 -1.63 -1.85 -1.79 -1.91
Net Debt to NOPAT		 3.42 2.10 2.00 1.66 1.46 1.75 3.66 3.59 3.74 2.76 4.84
Long-Term Debt to NOPAT		 -6.98 -4.52 -2.49 -2.31 -1.70 -1.81 -1.67 -1.63 -1.85 -1.79 -1.91
Altman Z-Score		 4.89 3.93 4.22 3.07 2.40 3.46 2.34 2.12 2.25 4.32 3.58
Noncontrolling Interest Sharing Ratio		 0.81% 0.86% 0.71% 0.66% 0.62% 0.58% 0.24% 0.22% 0.22% 0.22% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.69 1.88 1.60 1.61 1.57 1.84 1.63 1.70 1.79 2.37 2.03
Quick Ratio		 1.52 1.78 1.45 1.47 1.41 1.67 1.51 1.51 1.64 2.18 1.93
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 37 34 -125 -131 -124 -40 8.91 123 77 -37 85
Operating Cash Flow to CapEx		 201.36% -93.83% 282.22% 200.54% -56.09% -1,769.05% 62.72% 434.31% 1,168.29% -1,841.16% 1,342.87%
Free Cash Flow to Firm to Interest Expense		 9.43 3.94 -17.97 -22.97 -22.81 -7.25 1.63 23.35 15.27 -7.73 12.47
Operating Cash Flow to Interest Expense		 4.21 -1.02 3.78 4.13 -1.15 -34.18 1.10 7.07 16.96 -31.14 15.46
Operating Cash Flow Less CapEx to Interest Expense		 2.12 -2.11 2.44 2.07 -3.20 -36.12 -0.65 5.44 15.51 -32.83 14.31
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 3.93 3.94 3.37 2.98 2.89 2.98 2.22 2.24 2.17 2.27 1.91
Accounts Receivable Turnover		 15.84 19.76 20.20 16.40 13.87 17.15 17.76 17.37 14.56 18.95 20.17
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 47.76 45.42 44.12 42.33 41.58 40.95 41.58 42.48 42.82 42.48 40.86
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 23.05 18.47 18.07 22.25 26.32 21.28 20.56 21.01 25.06 19.27 18.09
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 23.05 18.47 18.07 22.25 26.32 21.28 20.56 21.01 25.06 19.27 18.09
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -49 -48 -53 -27 -7.67 1.07 -164 -145 -103 -9.35 -135
Invested Capital Turnover		 -106.53 -114.56 -22.67 -25.93 -36.49 -440.54 -11.51 -21.56 -28.83 -148.85 -17.02
Increase / (Decrease) in Invested Capital		 -41 -49 111 118 95 10 -30 -139 -99 0.58 -108
Enterprise Value (EV)		 3,415 2,008 2,093 1,344 799 1,472 955 728 866 1,955 1,810
Market Capitalization		 3,572 2,157 2,261 1,495 938 1,628 1,308 1,083 1,191 2,202 2,217
Book Value per Share		 $0.56 $0.52 $0.60 $0.65 $0.69 $0.83 $1.00 $1.11 $1.19 $1.27 $1.45
Tangible Book Value per Share		 $0.36 $0.32 $0.39 $0.44 $0.48 $0.62 $0.79 $0.90 $0.98 $1.06 $1.25
Total Capital		 431 422 328 337 294 320 351 372 385 400 433
Total Debt		 322 321 212 212 162 162 162 161 161 161 161
Total Long-Term Debt		 322 321 210 212 162 162 162 161 161 161 161
Net Debt		 -158 -149 -169 -152 -140 -157 -354 -356 -327 -249 -407
Capital Expenditures (CapEx)		 8.25 9.28 9.28 12 11 11 9.55 8.56 7.29 8.11 7.83
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -162 -161 -164 -136 -112 -98 -259 -236 -191 -95 -216
Debt-free Net Working Capital (DFNWC)		 317 310 217 228 190 221 257 282 297 315 352
Net Working Capital (NWC)		 317 310 216 228 190 221 257 282 297 315 352
Net Nonoperating Expense (NNE)		 5.58 15 13 11 18 18 14 12 15 21 17
Net Nonoperating Obligations (NNO)		 -158 -149 -169 -152 -140 -157 -354 -356 -327 -249 -407
Total Depreciation and Amortization (D&A)		 8.07 7.12 8.05 6.63 6.55 6.08 5.86 5.69 5.29 4.99 4.99
Debt-free, Cash-free Net Working Capital to Revenue		 -5.40% -5.95% -6.64% -6.10% -5.55% -5.39% -15.05% -14.52% -12.50% -6.62% -15.73%
Debt-free Net Working Capital to Revenue		 10.57% 11.46% 8.80% 10.20% 9.43% 12.09% 14.92% 17.35% 19.42% 21.94% 25.67%
Net Working Capital to Revenue		 10.57% 11.46% 8.73% 10.20% 9.43% 12.09% 14.92% 17.35% 19.42% 21.94% 25.67%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.05) ($0.15) ($0.14) ($0.13) ($0.25) ($0.25) ($0.19) ($0.15) ($0.20) ($0.32) ($0.22)
Adjusted Weighted Average Basic Shares Outstanding		 193.61M 190.79M 191.36M 190.89M 189.01M 186.21M 187.33M 188.40M 188.38M 181.21M 187.26M
Adjusted Diluted Earnings per Share		 ($0.05) ($0.15) ($0.14) ($0.13) ($0.25) ($0.25) ($0.19) ($0.15) ($0.20) ($0.32) ($0.22)
Adjusted Weighted Average Diluted Shares Outstanding		 193.61M 190.79M 191.36M 190.89M 189.01M 186.21M 187.33M 188.40M 188.38M 181.21M 187.26M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 197.84M 191.83M 191.70M 191.30M 191.20M 188.98M 0.00 185.99M 183.11M 181.21M 182.12M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.78 -16 -14 -13 -29 -29 -21 -17 -23 -36 -23
Normalized NOPAT Margin		 -0.41% -2.25% -1.97% -1.89% -4.58% -6.30% -4.56% -3.58% -5.18% -10.08% -6.49%
Pre Tax Income Margin		 -1.01% -4.43% -3.82% -3.52% -7.41% -10.15% -7.68% -6.16% -8.51% -15.71% -11.12%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -1.36 -2.65 -2.81 -3.21 -7.58 -7.64 -5.44 -4.41 -6.45 -10.87 -4.89
NOPAT to Interest Expense		 -0.96 -1.85 -1.97 -2.26 -5.30 -5.35 -3.81 -3.15 -4.53 -7.61 -3.44
EBIT Less CapEx to Interest Expense		 -3.45 -3.74 -4.15 -5.28 -9.63 -9.58 -7.19 -6.04 -7.90 -12.56 -6.04
NOPAT Less CapEx to Interest Expense		 -3.04 -2.94 -3.31 -4.32 -7.35 -7.28 -5.56 -4.77 -5.98 -9.30 -4.59
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.07% -0.08%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.07% -0.08%

Frequently Asked Questions About Alignment Healthcare's Financials

When does Alignment Healthcare's fiscal year end?

According to the most recent income statement we have on file, Alignment Healthcare's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Alignment Healthcare's net income changed over the last 5 years?

Alignment Healthcare's net income appears to be on an upward trend, with a most recent value of -$128.07 million in 2024, rising from -$44.73 million in 2019. The previous period was -$148.17 million in 2023. View Alignment Healthcare's forecast to see where analysts expect Alignment Healthcare to go next.

What is Alignment Healthcare's operating income?
Alignment Healthcare's total operating income in 2024 was -$101.56 million, based on the following breakdown:
  • Total Gross Profit: $2.70 billion
  • Total Operating Expenses: $2.81 billion
How has Alignment Healthcare revenue changed over the last 5 years?

Over the last 5 years, Alignment Healthcare's total revenue changed from $756.96 million in 2019 to $2.70 billion in 2024, a change of 257.2%.

How much debt does Alignment Healthcare have?

Alignment Healthcare's total liabilities were at $681.11 million at the end of 2024, a 57.0% increase from 2023, and a 121.2% increase since 2020.

How much cash does Alignment Healthcare have?

In the past 4 years, Alignment Healthcare's cash and equivalents has ranged from $202.90 million in 2023 to $466.60 million in 2021, and is currently $432.86 million as of their latest financial filing in 2024.

How has Alignment Healthcare's book value per share changed over the last 5 years?

Over the last 5 years, Alignment Healthcare's book value per share changed from 0.00 in 2019 to 0.52 in 2024, a change of 52.1%.


Related Companies

This page (NASDAQ:ALHC) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners
Elon Musk’s Frightening Warning Forces Trump’s Hand
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Watch This Robotics Demo Before July 23rd
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...
Brownstone Research | Sponsored
Urgent: Make this trade before you hit your pillow tonight…
Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they...
Timothy Sykes | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
URGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?
According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored